Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
50.53
-0.25 (-0.49%)
Oct 31, 2024, 4:00 PM EDT - Market closed

Amphastar Pharmaceuticals Revenue

Amphastar Pharmaceuticals had revenue of $182.39M in the quarter ending June 30, 2024, with 25.17% growth. This brings the company's revenue in the last twelve months to $712.89M, up 31.80% year-over-year. In the year 2023, Amphastar Pharmaceuticals had annual revenue of $644.40M with 29.14% growth.

Revenue (ttm)
$712.89M
Revenue Growth
+31.80%
P/S Ratio
3.45
Revenue / Employee
$404,822
Employees
1,761
Market Cap
2.46B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023644.40M145.41M29.14%
Dec 31, 2022498.99M61.22M13.98%
Dec 31, 2021437.77M87.92M25.13%
Dec 31, 2020349.85M27.49M8.53%
Dec 31, 2019322.36M27.69M9.40%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition